Several studies have demonstrated that FOXM1 promotes malignant progression by activating the expression of cell cycle genes in various cancers such as liver cancer, breast cancer, and ovarian cancer (Yang et al, 2013; Barger et al, 2015; Hu et al, 2019). This evidence concerns the gene FOXM1 and ovarian carcinoma.